Review Article

The Research Progression and Clinical Significance of Circular RNAs in Head and Neck Cancers

Table 1

Dysregulated circRNAs in HNC.

Primary siteNameGene symbolDysregulationSponge targetFunctionClinical valuePossible mechanismReference

OSCChsa_circ_0000140LATS2DownmiR-31Suppress cell proliferation, migration, and invasion and facilitated cell apoptosis in vitroA promising prognostic biomarker and potential treatment strategy for OSCCcirc_0000140/miR-31/LATS2 axis[30]
hsa_circ_0005379DownInhibits cancer cell proliferation, invasionA new therapeutic target for OSCC treatmentRegulate the epidermal growth factor receptor (EGFR) pathway[31]
hsa_circRNA_100533GNASDownmiR-933Inhibit cell proliferation and migration, promote cell apoptosis, and regulate GNAS expressionAn effective diagnostic biomarker and therapeutic target for patients with OSCChsa_circRNA_100533-miR-933-GNAS axis[32]
circ-PKD2APC2DownmiR-204-3pInhibit OSCC cell proliferation, migration, and invasion, induce apoptosis and cell cycle arrestA novel pathway involved in the pathogenesis of OSCC and may serve as a novel therapeutic target of OSCCcirc-PKD2/miR-204-3p/APC2 axis[33]
hsa_circRNA_102459DownRelate to clinical stage, tumor differentiation, and lymph node metastasis and suppressed TSCC1 cell proliferation, induced cell cycle G0/G1 phase arrest, and promoted apoptosisA tumor promoter and valuable diagnostic biomarkers of OSCC[34]
hsa_circRNA_043621UpRelate to clinical stage, tumor differentiation, and lymph node metastasis and suppressed TSCC1 cell proliferation, induced cell cycle G0/G1 phase arrest, and promoted apoptosisA tumor promoter and valuable diagnostic biomarkers of OSCC[34]
hsa_circ_009755DownAssociated with T stage of OSCCA potential biomarker for OSCC diagnosis[35]
hsa_circ_0072387DownRelated to TNM stage of OSCCA potential diagnostic biomarker[36]
circUHRF1UHRF1UpmiR-526b-5pAssociated with proliferation, migration, invasion, and epithelial-mesenchymal transformation (EMT) in vitro and the tumor growth in vivoA potential therapeutic targetcircUHRF1/miR-526b-5p/c-Myc/TGF-β1/ESRP1 feedback loop[37]
PTChsa_circ_0058124NUMBUpmiR-218-5pPromotes PTC cell proliferation, tumorigenicity, and tumor invasiveness both in vitro and in vivoA novel biomarker and a novel therapeutic target for intervening in PTC progressionhsa_circ_0058124/NOTCH3/GATAD2A axis[40]
hsa_circ_0006156FNDC3BUpmiR-1178Knockdown of circFNDC3B inhibited cell proliferation and promoted cell apoptosis in PTC cellsA promising therapeutic target for the treatment of PTC patientshsa_circ_0006156/miR-1178/TLR4 pathway[43]
circFOXM1FOXM1UpmiR-1179circFOXM1 downregulation inhibited tumor growth of PTC in vitro and in vivoA promising therapeutic target for the treatment of PTC patientscircFOXM1/miR-1179/high-mobility group box 1 (HMGB1) axis[44]
circBACH2LMO4UpmiR-139-5pSuppress proliferation, migration, and invasionA promising prognostic biomarker and potential treatment strategy for PTCcircBACH2/miR-139-5p/LMO4 axis[45]
circRAPGEF5RAPGEF5UpmiR-198Beneficial to proliferation, migration, and invasion in vitroA potential biomarker and therapeutic target for the management of PTCcircRAPGEF5/miR-198/FGFR1 axis[46]
LSCChsa_circ_0059354RASSF2UpmiR-302b-3pSilencing circRASSF2 suppresses progression of LSCC by interacting with miR-302b-3p and decreasing inhibiting IGF-1R expressionA potential biomarker for the diagnosis and prognosis of LSCChsa_circ_0059354/miR-302b-3p/IGF-1R axis[50]
hsa_circ_0042666TGFBR3DownmiR-2238Associated with advanced tumor stage, lymph node metastasis, and poor overall survival in LSCC patientsA promising target for LSCC treatment and a tumor suppressorhsa_circ_0042666/miR-223/TGFBR3 axis[49]
ciRS-7CDR1asUpmiR-7Relate with high TNM stages, poorly differentiated tumors, lymph node metastases and poor prognosis of LSCC patients.
Enhance cell vitality and promoted the proliferation and migration
An oncogene that promotes LSCC progressionmiR-7/CCNE1/PIK3CD signaling pathway[51]
NPCcircRNA_000543PDGFRBUpmiR-9Associated with poorer overall survival in NPC patientsA potential therapeutic target for radioresistant NPCmiR-9/platelet-derived growth factor receptor B (PDGFRB) axis[53]
HSCChsa_circ_0058106UpmiR-185-3pPrevent HSCC cells from undergoing apoptosisProvide potential candidates for future mechanism studies[54]
hsa_circ_0036722RHCGDownmiR-671-5pFacilitate the invasiveness of HSCCProvide potential candidates for future mechanism studies[54]
MEChsa_circ_0012342DownClosely related to the pathogenesis of MECPotential prognostic biomarkers and therapeutic target of MEC[55]

Dysregulated circRNAs in HNC. Abbreviations: OSCC: oral squamous cell cancer; PTC: papillary thyroid cancer; LSCC: laryngeal squamous cell cancer; NPC: nasopharyngeal cancer; HSCC: hypopharyngeal squamous cell cancer; MEC: mucoepidermoid carcinoma.